Evidence map›Paper›PMID 30858759›Full record

ArticleCancer cell international2019

miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.

Fei Wang, Dinglan Wu, Zhanping Xu, Jianxiang Chen, Jiye Zhang, Xiaojuan Li, Shiliang Chen, Fengrong He, Jianbing Xu, Liangju Su and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. A co-regulatory network ofAmerican journal of cancer research · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13.Computational and mathematical methods in medicine · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Fei Wang *1Department of Urology, Hainan General Hospital, Haikou, China.
Dinglan Wu *2Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong Province China.
Zhanping Xu *3Department of Urology, Foshan Hospital of TCM, Foshan, Guangdong Province China.
Jianxiang ChenDepartment of Urology, Affiliated Hospital of Xiangnan College, Chenzhou, China.
Jiye Zhang5Central Laboratory, Hainan General Hospital, Haikou, China.
Xiaojuan Li5Central Laboratory, Hainan General Hospital, Haikou, China.
Shiliang Chen6Department of Pathology, Hainan General Hospital, Haikou, China.
Fengrong He1Department of Urology, Hainan General Hospital, Haikou, China.
Jianbing Xu1Department of Urology, Hainan General Hospital, Haikou, China.
Liangju Su1Department of Urology, Hainan General Hospital, Haikou, China.
Defan Luo1Department of Urology, Hainan General Hospital, Haikou, China.
Shufang ZhangCentral Laboratory, Affiliated Haikou Hospital Xiangya School of Medicine Central South University (HaiKou Municipal People Hospital), Haikou, Hainan China.
Weifu Wang1Department of Urology, Hainan General Hospital, Haikou, China.ORCID 0000-0001-9439-1054
Hainan General Hospital · CNCentral South University · CNFoshan Hospital of TCM · CNSouthern Medical University Shenzhen Hospital · CNXiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman bladder cancer is one of the common malignant tumors, and it mainly occurs in men. miR-182-5p, a member of miR-183 family, acts as tumor suppressor or oncogene in various kinds of tumors. In this study, we first investigate that the absence of miR-182-5p in human bladder cancer promotes tumor growth by regulating the expression of Cofilin 1, an actin modulating-protein.

methodsHuman bladder tumor tissue specimens were collected to detect the expression of miR-182-5p and Cofilin 1 by qRT-PCR. Luciferase activity assay was performed to demonstrate the regulation of Cofilin 1 mRNA 3'UTR by miR-182-5p. Then, cell experiments were performed to analysis the effect of miR-182-5p/Cofilin 1 pathway on tumor cell proliferation, migration, invasion and colony forming efficiency. Finally, xenograft tumor models were established to evaluate the role of miR-182-5p in tumorigenesis abilities in vivo.

resultsqRT-PCR and Western blotting analysis showed that Cofilin 1 expression was up-regulated in both bladder cancer tissues and cell lines compared with normal. Luciferase activity assay showed that miR-182-5p specifically targets Cofilin 1 mRNA 3'UTR and represses the expression of Cofilin 1. Also, miR-182-5p inhibited bladder tumor cell proliferation, migration, invasion and colony forming efficiency. Furthermore, xenograft tumor model assay showed that miR-182-5p plays a negative role in bladder cancer tumorigenesis abilities in vivo.

conclusionPresent results suggest that miR-182-5p could inhibit human bladder tumor growth by repressing Cofilin 1 expression. Our findings may provide a new horizon for exploring therapeutic target of bladder cancer.

Indexed as

Bladder cancerCofilin 1InvasionMigrationmiR-182-5pProliferation

Identifiers

PMID30858759
PMCPMC6394052
OpenAlexW2923772589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.